Etanercept 25mg Injection

Etacept 25mg Injection contains an active component as Etanercept. It is commercially known as Enbrel and is a potent TNF inhibitor utilized to treat various autoimmune conditions, including rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis. Rheumatoid arthritis is an autoimmune disorder characterized by chronic inflammation of the joints, leading to pain, swelling, and potential joint deformity. Psoriatic arthritis is an inflammatory joint condition occurring in some individuals with psoriasis, leading to joint pain, stiffness, and swelling. Ankylosing spondylitis is a type of arthritis that primarily affects the spine, causing pain, stiffness, and potential fusion of the vertebrae, leading to reduced flexibility. Juvenile idiopathic arthritis is a group of chronic arthritic conditions affecting children under 16, causing joint inflammation, pain, and potential damage. Etacept 25mg Injection suppresses the immune system's overactive response and reduces inflammation, effectively improving the symptoms of these chronic inflammatory diseases.